Aspirin Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis

<b>Background:</b> Given aspirin’s biologic plausibility for antifibrotic and antineoplastic effects, we conducted a systematic review and meta-analysis to examine the association between aspirin use and major liver-related outcomes in metabolic dysfunction-associated steatotic liver disease (MASLD)...

Descrición completa

Detalles Bibliográficos

Principais autores:	Fares Jamal, Abdullah Hamad, Amani Elshaer, Pierce L. Claassen, Taylor Viggiano, Michele Barnhill, David M. H. Chascsa, Hugo E. Vargas, Bashar A. Aqel, Blanca C. Lizaola-Mayo
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2026-05-01
Series:	Biomedicines
Assuntos:	MASLD MASH aspirin acetylsalicylic acid NAFLD NASH
Acceso en liña:	https://www.mdpi.com/2227-9059/14/6/1249
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!